AbbVie Inc. (NYSE: ABBV) is a large market cap stock with a market cap of 104307.67. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 18.16, a forward P/E of 11.19 and EPS of 3.49. At a stock price of 63.35 (0.02%) it has a dividend yield of 3.60%.
EPS growth for the last five years have been 3.50%, more recently this last year it has grown by 185.20%. The next year growth is going to be about 17.71% and more long-term 16.25% after five years. EPS growth quarter over quarter is 17.90%. Sales growth for the past five years have been 7.90% and sales growth quarter over quarter is 17.80%.
For performance, AbbVie Inc. the past week has seen a gain of -1.11%. For the last month performance for AbbVie Inc. is -5.08%. While the last quarter is 4.94% and half year, 16.63%. Finally for the year, performance is 10.57%.
The 52-week high for AbbVie Inc., is at -7.00%, and for the 52-week low it comes to a value of 43.45%. The 20-day simple moving average is -2.54% and 6.93% for the 200-day simple moving average.
Volatility for the week is at 1.73%, and for the month it is 1.48%. AbbVie Inc., has a target price of 71.47.
In terms of debt, long term debt/equity is 6.62, and for total debt/equity AbbVie Inc. has 6.71. The gross margin is 78.60%, while operating margin is 35.00%, the profit margin is 23.10%. The current ratio is 1.8 and the quick ratio is 1.6.
Insider ownership is at 0.10%, with instituitional ownership at 71.90%. AbbVie Inc. has a payout ratio of 63.30%. With the total shares outstanding coming to 1646.53. The shares float is 1627.2, with the float short at 2.95%, with short ratio coming to 6.68.
In terms of returns, the return on assets see AbbVie Inc., get 10.00%, with its returns on investment at 16.90%. Return on equity is 119.80%. So will the investors see the target price of 71.47, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.